IVVD - Invivyd Inc.

IVVD - Invivyd Inc.

https://invivyd.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Steven Cohen's Biotech Bets Are Getting Bolder - And Smaller - Invivyd ( NASDAQ:IVVD )

Benzinga • 2 weeks, 2 days ago • score: 0.54

Steven Cohen bought $17.2 million of Invivyd on Tuesday. Point72 liftedDesign stake by 62.8% on Wednesday. Get a Year of Fast, Actionable Trade Alerts for 60% Off This Labor Day Steven Cohen isn't afraid of volatility - and his latest moves show he's diving headfirst into small-cap biotech.

Invivyd to Participate in Upcoming Investor Conferences - Invivyd ( NASDAQ:IVVD )

Benzinga • 2 weeks, 5 days ago • score: 0.33

WALTHAM, Mass., Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- Invivyd, Inc. IVVD today announced that it will present at the following investor conferences: Cantor Global Healthcare Conference 2025 Fireside Chat Date: Wednesday, September 3, 2025 Fireside Chat Time: 2:10 PM ET Location: New York, NY

Invivyd to Participate in Upcoming Investor Conferences

GlobeNewswire • 2 weeks, 5 days ago • score: 0.36

WALTHAM, Mass., Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- Invivyd, Inc. ( Nasdaq: IVVD ) today announced that it will present at the following investor conferences: ...

Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter's Option to Purchase Additional Shares

GlobeNewswire • 3 weeks, 2 days ago • score: 0.14

WALTHAM, Mass., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Invivyd, Inc. ( Invivyd ) ( Nasdaq: IVVD ) today announced the closing of its previously announced underwritten public offering of 89,234,480 shares of its common stock, which includes the exercise in full by the underwriter of its option to ...

Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire • 3 weeks, 4 days ago • score: 0.14

WALTHAM, Mass., Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Invivyd, Inc. ( Invivyd ) ( Nasdaq: IVVD ) today announced the pricing of an underwritten public offering of 74,811,404 shares of its common stock at an offering price of $0.52 per share and, to certain investors, in lieu of common stock, ...

Invivyd Announces Proposed Public Offering of Common Stock - Invivyd ( NASDAQ:IVVD )

Benzinga • 3 weeks, 4 days ago • score: 0.09

WALTHAM, Mass., Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Invivyd, Inc. ( Invivyd ) IVVD today announced that it has commenced an underwritten public offering of shares of its common stock.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.

52W High

$2.74

52W Low

$0.36

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.55

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

6.51

EV/EBITDA (<8 favorable)

0.78

EV/Revenue (<3 favorable)

4.47

P/S (TTM) (<3 favorable)

5.17

P/B (<3 favorable)

5.58

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

19.20%

Institutions (25–75% balanced)

49.16%

Shares Outstanding

209,377,000

Float

72,176,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

46,210,000

Gross Profit (TTM)

43,161,000

EPS (TTM)

-0.92

Profit Margin (>10% good)

-2.38%

Operating Margin (TTM) (higher better)

-1.28%

ROE (TTM) (>15% strong)

-1.20%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

4.21

Momentum

Bearish momentum

Value

0.1858

Previous

0.1628

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025